ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway

Sun, Liping; Liu, Shuguang; Wang, Xiaopai; Zheng, Xuefeng; Chen, Ya; Shen, Hong*南方医科大学; 中山大学; 1
Journal of Translational Medicine2021-5-20DOI: 10.1186/s12967-021-02877-4
16被引7阅读
引用收藏
分享

摘要

Background Eukaryotic translation initiation factor 6 (eIF6) has a crucial function in the maturation of 60S ribosomal subunits, and it controls the initiation of protein translation. Although emerging studies indicate that eIF6 is aberrantly expressed in various types of cancers, the functions and underlying molecular mechanisms of eIF6 in the pathological progression of hepatocellular carcinoma (HCC) remain unclear. This study aimed to evaluate the potential diagnostic and prognostic value of eIF6 in patients with HCC. Methods HCC samples enrolled from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and our cohort were used to explore the role and mechanism of eIF6 in HCC. The diagnostic power of eIF6 was verified by receiver operating characteristic curve (ROC) analysis and its prognostic value was assessed by Kaplan-Meier analysis, and then related biological functions of eIF6 were determined in vitro and in vivo cancer models. In addition, potential molecular mechanism of eIF6 in HCC was unveiled by the gene set enrichment analysis and western blot assay. Results We demonstrated that eIF6 expression was markedly increased in HCC, and elevated eIF6 expression correlated with pathological progression of HCC. Besides, eIF6 served as not only a new diagnostic biomarker but also an independent risk factor for OS in HCC patients. Functional studies indicated that the deletion of eIF6 displayed tumor-suppressor activity in HCC cells. Furthermore, we found that eIF6 could activate the mTOR-related signaling pathway and regulate the expression level of its target genes, such as CCND1, CDK4, CDK6, MYC, CASP3 and CTNNBL1, and these activities promoted proliferation and invasion of HCC cells. Conclusions The findings of this study provided a novel basis for understanding the potential role of eIF6 in promoting tumor growth and invasion, and exploited a promising strategy for improving diagnosis and prognosis of HCC.

学科与关键词

关键词
EIF6MTORHepatocellular carcinomaCell proliferationPrognosis
相关
加载中…
  • TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing; Liu, Maosheng; Wu, Fengfei; Ou, Shiyu; Wang, Weidong; Fei, Jieying; Xie, Fang; Bai, Lan*EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28(1): 48.被引 7
  • IGF2BP3-induced activation of EIF5B contributes to progression ofhepatocellular carcinoma cells br
    LI, Xiaoyin; Wang, Qian; Liang, Hongfeng; Chen, Shisheng; Chen, Haiwen; Lu, Yaoyong*; Yang, Changfu*Oncology Research, 2022, 30(2): 77-87.
  • EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
    Li, Linjing*; Li, Xin; Zhang, Qingyan; Ye, Tao; Zou, Shuli; Yan, JingAmerican Journal of Cancer Research, 2021, 12(16): 4774-4779.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2021-05-20
卷期
第 19 卷, 第 1 期
页码
216
DOI
10.1186/s12967-021-02877-4
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Futian District Health Public Welfare Scientific Research Project of Shenzhen [FTWS2018043, FTWS2019014, FTWS2018047]

作者

  • S

    Sun, Liping (第一作者)

    southern med univ

  • L

    Liu, Shuguang

    sun yat sen univ

查看全部 6 位作者收起作者
  • W

    Wang, Xiaopai

    1

  • Z

    Zheng, Xuefeng

  • C

    Chen, Ya

    southern med univ

  • S

    Shen, Hong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417